Epoprostenol Campuspharma 1.5 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

epoprostenol campuspharma 1.5 mg

campuspharma ab - epoprostenolnatrium - pulver og væske til infusjonsvæske, oppløsning - 1.5 mg

Epoprostenol Campuspharma 0.5 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

epoprostenol campuspharma 0.5 mg

campuspharma ab - epoprostenolnatrium - pulver og væske til infusjonsvæske, oppløsning - 0.5 mg

Flolan 0.5 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

flolan 0.5 mg

glaxosmithkline as - epoprostenolnatrium - pulver og væske til infusjonsvæske, oppløsning - 0.5 mg

Flolan 1.5 mg নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

flolan 1.5 mg

glaxosmithkline as - epoprostenolnatrium - pulver og væske til infusjonsvæske, oppløsning - 1.5 mg

Estrumat vet 0.25 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

estrumat vet 0.25 mg/ ml

intervet international bv - 5831 an - kloprostenolnatrium - injeksjonsvæske, oppløsning - 0.25 mg/ ml

Genestran Vet 75 mikrog/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

genestran vet 75 mikrog/ ml

animedica gmbh - r-kloprostenolnatrium - injeksjonsvæske, oppløsning - 75 mikrog/ ml

Syncroprost 0.25 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

syncroprost 0.25 mg/ ml

ceva santé animale - kloprostenolnatrium - injeksjonsvæske, oppløsning - 0.25 mg/ ml

Volibris ইউরোপীয় ইউনিয়ন - নরওয়েজীয় - EMA (European Medicines Agency)

volibris

glaxosmithkline (ireland) limited - ambrisentan - hypertensjon, pulmonal - antihypertensiva, - volibris is indicated for treatment of pulmonary arterial hypertension (pah) in adult patients of who functional class (fc) ii to iii, including use in combination treatment (see section 5.  efficacy has been shown in idiopathic pah (ipah) and in pah associated with connective tissue disease. volibris is indicated for treatment of pah in adolescents and children (aged 8 to less than 18 years) of who functional class (fc) ii to iii including use in combination treatment. efficacy has been shown in ipah, familial, corrected congenital and in pah associated with connective tissue disease (see section 5.

Lanoxin 50 mikrog/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

lanoxin 50 mikrog/ ml

aspen pharma trading limited - digoksin - mikstur, oppløsning - 50 mikrog/ ml

Lanoxin 0.25 mg/ ml নরওয়ে - নরওয়েজীয় - Statens legemiddelverk

lanoxin 0.25 mg/ ml

aspen pharma trading limited - digoksin - injeksjonsvæske, oppløsning - 0.25 mg/ ml